22nd Annual Winter Lung Cancer Conference®

*Lunch and OncLive Ask the Expert: Advancing Care in EGFR-Mutant NSCLC: Spotlight on Antibody-Drug Conjugates (ADCs)

CE Symposium: Cases and Conversations: Incorporating Recent Updates in the Treatment of Metastatic ALK-Positive NSCLC

CE Symposium: A Breath of Strength: Managing Cancer Associated LEMS and Lung Cancer as One

Current Unmet Needs in Lung Cancer Screening

Future of Immunotherapy in Lung Cancer: What's Next?

Medical Crossfire®: Who Should Get Neoadjuvant vs Perioperative vs Definitive Local Therapy?

Current Strategies in the Adjuvant Setting

Expanding Boundaries: Targeting BRAF and MET

Breaking Barriers: Targeting ROS1, NTRK, ALK, and NRG1 Fusions

Next-Generation TKIs in Lung Cancer: Innovations on the Horizon

The Evolving Landscape of ADCs: Spotlight on HER2 and Beyond

Case-Based Panel: A Real-World Discussion

How to Practically Implement Palliative Care

Using the NGS Report to Tailor IO Therapy

Preventing and Overcoming Resistance to Checkpoint Inhibitors (CPIs)

Medical Crossfire: Treatment Selection and Sequencing in EGFR-mutant NSCLC

Atypical EGFR Mutations: Navigating Uncommon Pathways

Cracking the Code: Advances in EGFR Exon 20 Insertions